Dexcom Inc (NASDAQ: DXCM) has a price-to-earnings ratio that is above its average at 63.14x. The stock has a 36-month beta value of 1.45. Opinions on the stock are mixed, with 18 analysts rating it as a “buy,” 6 as “overweight,” 3 as “hold,” and 0 as “sell.”
The average price predicted for Dexcom Inc (DXCM) by analysts is N/A, which is -$4109899.64 below the current market price. The public float for DXCM is 386.61M, and at present, short sellers hold a 2.43% of that float. On July 01, 2025, the average trading volume of DXCM was 4.11M shares.
DXCM) stock’s latest price update
Dexcom Inc (NASDAQ: DXCM) has experienced a decline in its stock price by -3.64 compared to its previous closing price of 87.29. Nevertheless, the company has seen a -3.95% plunge in its stock price over the last five trading sessions. businesswire.com reported 2025-07-01 that SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2025 financial results after market close on Wednesday, July 30, 2025. Management will hold a conference call to review the company’s second quarter 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and wil.
DXCM’s Market Performance
Dexcom Inc (DXCM) has seen a -3.95% fall in stock performance for the week, with a -1.96% decline in the past month and a 23.17% surge in the past quarter. The volatility ratio for the week is 4.41%, and the volatility levels for the past 30 days are at 2.91% for DXCM. The simple moving average for the past 20 days is -0.09% for DXCM’s stock, with a 8.71% simple moving average for the past 200 days.
Analysts’ Opinion of DXCM
Many brokerage firms have already submitted their reports for DXCM stocks, with Truist repeating the rating for DXCM by listing it as a “Buy.” The predicted price for DXCM in the upcoming period, according to Truist is $102 based on the research report published on June 16, 2025 of the current year 2025.
Goldman, on the other hand, stated in their research note that they expect to see DXCM reach a price target of $104. The rating they have provided for DXCM stocks is “Buy” according to the report published on May 30th, 2025.
Mizuho gave a rating of “Outperform” to DXCM, setting the target price at $85 in the report published on April 10th of the current year.
DXCM Trading at 2.82% from the 50-Day Moving Average
After a stumble in the market that brought DXCM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.22% of loss for the given period.
Volatility was left at 2.91%, however, over the last 30 days, the volatility rate increased by 4.41%, as shares sank -0.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +23.87% upper at present.
During the last 5 trading sessions, DXCM fell by -3.01%, which changed the moving average for the period of 200-days by +24.05% in comparison to the 20-day moving average, which settled at $84.23. In addition, Dexcom Inc saw -26.56% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DXCM starting from Stern Sadie, who sale 1,466 shares at the price of $85.06 back on Jun 26 ’25. After this action, Stern Sadie now owns 108,155 shares of Dexcom Inc, valued at $124,698 using the latest closing price.
SADIE STERN, the Officer of Dexcom Inc, proposed sale 1,466 shares at $85.06 during a trade that took place back on Jun 26 ’25, which means that SADIE STERN is holding N/A shares at $124,698 based on the most recent closing price.
Stock Fundamentals for DXCM
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.59 for the gross margin
The net margin for Dexcom Inc stands at 0.13. The total capital return value is set at 0.17. Equity return is now at value 23.72, with 8.09 for asset returns.
Based on Dexcom Inc (DXCM), the company’s capital structure generated 0.53 points at debt to capital in total, while cash flow to debt ratio is standing at 0.37. The debt to equity ratio resting at 1.14. The interest coverage ratio of the stock is 43.93.
Currently, EBITDA for the company is 945.7 million with net debt to EBITDA at 1.89. When we switch over and look at the enterprise to sales, we see a ratio of 8.31. The receivables turnover for the company is 3.59for trailing twelve months and the total asset turnover is 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.50.
Conclusion
To sum up, Dexcom Inc (DXCM) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
